Pfizer’s RSV Vaccine: US FDA Panel Wants Robust Safety Program With Public Accountability

 
• By Sarah Karlin-Smith
  
babies
Pfizer’s maternal RSV vaccine got positive VRBPAC votes on 18 May • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers